<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Physiology and Pharmacology</title>
<title_fa></title_fa>
<short_title>Physiol Pharmacol</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ppj.phypha.ir</web_url>
<journal_hbi_system_id>32</journal_hbi_system_id>
<journal_hbi_system_user>journal32</journal_hbi_system_user>
<journal_id_issn>24765236</journal_id_issn>
<journal_id_issn_online>24765244</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.22034</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>(previous ISSN: 17350581)</journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1401</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2022</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<volume>26</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Anticonvulsant effects of squill oxymel (a traditional formulation) in mice</title>
	<subject_fa>Pharmacokinetics/Dynamics</subject_fa>
	<subject>Pharmacokinetics/Dynamics</subject>
	<content_type_fa>Short communication</content_type_fa>
	<content_type>Short communication</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Introduction: &lt;/span&gt;&lt;/strong&gt;&lt;span class=&quot;fontstyle2&quot;&gt;This study evaluated the anticonvulsant activity of the add-on &lt;/span&gt;&lt;span class=&quot;fontstyle3&quot;&gt;Drimia maritima &lt;/span&gt;&lt;span class=&quot;fontstyle2&quot;&gt;(squill) oxymel, used traditionally in the treatment of convulsion, in animal model. &lt;/span&gt;&lt;span class=&quot;fontstyle0&quot;&gt;&lt;strong&gt;Methods:&lt;/strong&gt; &lt;/span&gt;&lt;span class=&quot;fontstyle2&quot;&gt;Albino mice pretreated with squill oxymel in different doses of 50, 100, 200 and 400mg/kg by oral gavage, 15min prior to injection of pentylenetetrazole (PTZ). Animals pretreated with flumazenil to determine the mechanism of anticonvulsant action. The total flavonoid content of squill oxymel was also determined.&lt;strong&gt; &lt;/strong&gt;&lt;/span&gt;&lt;span class=&quot;fontstyle0&quot;&gt;&lt;strong&gt;Results:&lt;/strong&gt; &lt;/span&gt;&lt;span class=&quot;fontstyle2&quot;&gt;Squill oxymel prolonged the onset of seizures and decreased the duration of seizures compared to control group. Diazepam used as a reference drug for its anticonvulsive effects, showed complete inhibition of seizure. This study revealed that squill oxymel has significant anticonvulsant effect in PTZ-induced seizures in mice and these effects may be related to its effect on benzodiazepines&amp;rsquo; receptors on GABA complex. &lt;/span&gt;&lt;span class=&quot;fontstyle0&quot;&gt;&lt;strong&gt;Conclusion:&lt;/strong&gt; &lt;/span&gt;&lt;span class=&quot;fontstyle2&quot;&gt;These results confirmed the traditional use of squill oxymel in Iranian traditional medicine for treatment of epilepsy. The clarification of mechanisms involved needs further studies.&lt;/span&gt;&lt;/div&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Drimia maritime, Squill, Oxymel, Anticonvulsant, Pentylenetetrazole</keyword>
	<start_page>1</start_page>
	<end_page>6</end_page>
	<web_url>http://ppj.phypha.ir/browse.php?a_code=A-15-1428-2&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Meysam</first_name>
	<middle_name></middle_name>
	<last_name>Abolmaali</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>3200319475328460030953</code>
	<orcid>3200319475328460030953</orcid>
	<coreauthor>No</coreauthor>
	<affiliation> Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Manijeh</first_name>
	<middle_name></middle_name>
	<last_name>Motevalian</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>3200319475328460030954</code>
	<orcid>3200319475328460030954</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Saeed</first_name>
	<middle_name></middle_name>
	<last_name>Mehrzadi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>3200319475328460030955</code>
	<orcid>3200319475328460030955</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Razi Drug Research Centre, Iran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Asie</first_name>
	<middle_name></middle_name>
	<last_name>Shojaii</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>shojaii.a@iums.ac.ir</email>
	<code>3200319475328460030956</code>
	<orcid>3200319475328460030956</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Traditional Pharmacy, School of Persian Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
